The no-reflow phenomenon in the coronary circulation

Thomas J Kiernan1, Nicholas J Ruggiero, Juan M Bernal

  • 1Division of Interventional Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. tjkiernan@partners.org

Insights

The no-reflow phenomenon, a complication of percutaneous coronary intervention, involves persistent reduced blood flow despite successful lesion treatment. This review covers its pathophysiology, predictors, and management strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • The no-reflow phenomenon is a critical complication following percutaneous coronary intervention (PCI).
  • It is characterized by impaired distal microvascular perfusion despite successful epicardial artery revascularization.
  • Understanding its mechanisms is crucial for improving PCI outcomes.

Purpose of the Study:

  • To provide a comprehensive review of the no-reflow phenomenon.
  • To elucidate the underlying pathophysiology of coronary no-reflow.
  • To identify predictors and summarize current treatment and prevention strategies for no-reflow.

Main Methods:

  • This review synthesizes current literature on the no-reflow phenomenon.
  • It discusses established and emerging concepts in pathophysiology.
  • It analyzes pharmacological and mechanical interventions.

Main Results:

  • The pathophysiology involves microvascular dysfunction, distal embolization, and reperfusion injury.
  • Predictors include lesion characteristics, procedural factors, and patient comorbidities.
  • Current strategies focus on prevention and treatment through pharmacologic agents and mechanical devices.

Conclusions:

  • No-reflow remains a significant challenge in interventional cardiology.
  • A multi-faceted approach addressing pathophysiology and utilizing tailored strategies is essential.
  • Further research is needed to optimize prevention and treatment protocols.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...